Secondary Hypogonadism: Clinical Trials

5 trials for Secondary Hypogonadism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5

Follow Secondary Hypogonadism: new trials by email Literature Review of Secondary Hypogonadism trials Research Report on Secondary Hypogonadism

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)
Androxal (enclomiphene citrate), Testosterone - Secondary Hypogonadism
Phase 2CompletedRepros Therapeutics Inc.602011-06-012015-09-23
Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism
Placebo, topical testosterone, Androxal - Secondary Hypogonadism
Phase 2CompletedRepros Therapeutics Inc.832011-01-012014-07-28
Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus
Placebo, Androxal - Type 2 Diabetes Mellitus, Secondary Hypogonadism
Phase 2CompletedRepros Therapeutics Inc.1022010-10-012014-07-24
Pharmacokinetic Study to Determine Time to Steady-state
Testosterone undecanoate - Male Hypogonadism, Primary Hypogonadism
Phase 2CompletedClarus Therapeutics, Inc.152009-07-012020-12-11
To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone
25 mg Androxal, Testim 1% - Secondary Hypogonadism
Phase 2CompletedRepros Therapeutics Inc.172008-06-012015-08-19

Narrower conditions

Hypogonadism (5)  ·  Diabetes Mellitus, Type 2 (1)  ·  Eunuchism (1)

Broader conditions

Endocrine System Diseases (5)  ·  Gonadal Disorders (5)  ·  Diabetes Mellitus (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Enclomiphene (4)  ·  Testosterone (3)  ·  testosterone undecanoate (1)

Sponsors

Repros Therapeutics Inc. (4)  ·  Clarus Therapeutics, Inc. (1)

Countries

United States (5)

Top investigators

Glenn Cunningham, MD (1)  ·  Gregory Flippo, MD (1)  ·  Jolene Berg, MD (1)  ·  Larry Lipshultz, MD (1)  ·  Ronald Wiehle, PhD (1)

Results publications

PMID 21474786, PMID 25044085